Relationship and Prognostic Value of Endogenous Interferon-??, ??2-Microglobulin, and Neopterin Serum Levels in Patients with Kaposi Sarcoma and AIDS

Susan E. Krown(Memorial Sloan Kettering Cancer Center), Douglass Chapman(Memorial Sloan Kettering Cancer Center), Denise Bundow, Neal Flomenberg(Memorial Sloan Kettering Cancer Center), Donna Niedzwiecki(Duke University), Ravi B. Bhalla(Memorial Sloan Kettering Cancer Center)
JAIDS Journal of Acquired Immune Deficiency Syndromes
September 1, 1991
10.1097/00126334-199109000-00008
Cited by 55

Related Papers

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
|JAMA|2017|891
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
|Journal of Clinical Oncology|2010|840
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
|New England Journal of Medicine|1983|358